Skip to main content
. 2021 Feb 26;26(5):1257. doi: 10.3390/molecules26051257

Figure 11.

Figure 11

(A) 3D interactions of [(2R,3R)-2-[2-[6-[(2R,3R)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-2,3,4-trihydroxyphenyl]-3,4,5-trihydroxyphenyl]-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate and HCV E2 protein having binding affinity −12. (B) Surface representation of interaction.